View Financial HealthElate Holdings 배당 및 자사주 매입배당 기준 점검 0/6Elate Holdings 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률-36.3%자사주 매입 수익률총 주주 수익률-36.3%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Apr 27Elate Holdings Limited, Annual General Meeting, Jun 05, 2026Elate Holdings Limited, Annual General Meeting, Jun 05, 2026, at 11:00 China Standard Time.공시 • Feb 06Elate Holdings Limited to Report Fiscal Year 2025 Results on Mar 30, 2026Elate Holdings Limited announced that they will report fiscal year 2025 results on Mar 30, 2026공시 • Jul 02Elate Holdings Limited to Report First Half, 2025 Results on Aug 29, 2025Elate Holdings Limited announced that they will report first half, 2025 results on Aug 29, 2025공시 • Apr 25Elate Holdings Limited, Annual General Meeting, Jun 06, 2025Elate Holdings Limited, Annual General Meeting, Jun 06, 2025, at 11:00 China Standard Time.공시 • Feb 03Elate Holdings Limited to Report Fiscal Year 2024 Results on Mar 28, 2025Elate Holdings Limited announced that they will report fiscal year 2024 results on Mar 28, 2025Reported Earnings • Sep 26First half 2024 earnings released: EPS: US$0.076 (vs US$0.001 in 1H 2023)First half 2024 results: EPS: US$0.076 (up from US$0.001 in 1H 2023). Revenue: US$65.8m (up 29% from 1H 2023). Net income: US$27.7m (up US$27.4m from 1H 2023). Profit margin: 42% (up from 0.6% in 1H 2023).공시 • Jul 04Elate Holdings Limited to Report First Half, 2024 Results on Aug 30, 2024Elate Holdings Limited announced that they will report first half, 2024 results on Aug 30, 2024공시 • Apr 28Elate Holdings Limited, Annual General Meeting, Jun 06, 2024Elate Holdings Limited, Annual General Meeting, Jun 06, 2024, at 11:00 China Standard Time. Agenda: To receive and adopt the Audited Financial Statements and the Reports of the Directors and Auditor for the year ended 31 December 2023; to re-elect the Ms. Zhang Xue as an executive director; to re-elect the Dr. Yan Shao Shi as an independent non-executive director; to authorize the board of directors to fix the remuneration of the aforesaid directors; to re-appoint BDO Limited as auditor and authorize the Board to fix their remuneration; and to consider other business matters.Reported Earnings • Mar 30Full year 2023 earnings released: EPS: US$0.005 (vs US$0.002 in FY 2022)Full year 2023 results: EPS: US$0.005 (up from US$0.002 in FY 2022). Revenue: US$105.7m (up 5.5% from FY 2022). Net income: US$1.82m (up 217% from FY 2022). Profit margin: 1.7% (up from 0.6% in FY 2022).공시 • Mar 01Elate Holdings Limited to Report Fiscal Year 2023 Results on Mar 28, 2024Elate Holdings Limited announced that they will report fiscal year 2023 results on Mar 28, 2024Reported Earnings • Sep 03First half 2023 earnings released: EPS: US$0.001 (vs US$0.01 in 1H 2022)First half 2023 results: EPS: US$0.001 (down from US$0.01 in 1H 2022). Revenue: US$51.0m (down 3.6% from 1H 2022). Net income: US$300.0k (down 92% from 1H 2022). Profit margin: 0.6% (down from 6.7% in 1H 2022). The decrease in margin was primarily driven by lower revenue.공시 • Aug 25Elate Holdings Limited Provides Group Earnings Guidance for the Six Months Ended 30 June 2023Elate Holdings Limited provided group earnings guidance for the six months ended 30 June 2023. For the period, the company is expected that the Group to record a net profit attributable to shareholders of approximately USD 0.3 million (corresponding period in 2022: net profit of approximately USD 3.5 million). The Board considers that the decrease in net profit for the six months ended 30 June 2023 was mainly attributable to the decrease in selling price of natural graphite products and increase in the cost of graphite production, which was mainly due to the over capacity of artificial graphite in China.공시 • Jul 12Elate Holdings Limited Announces Executive ChangesThe board of directors (the "Board" or "Directors") of Elate Holdings Limited (the "Company") announce that with effect from 11 July 2023, Dr. Yan Shao Shi ("Dr. Yan") has been appointed as an independent non-executive director, the chairman of the Board's remuneration committee, a member of audit committee and nomination committee. Dr. Yan Shao Shi, aged 39, is currently an Assistant Professor and a Ph.D. Advisor in Macau University of Science and Technology. Dr. Yan obtained her doctoral degree from Macau University of Science and Technology, and her teaching and research areas include design, culture and communications. There is no service contract between the Company and Dr. Yan. She is not appointed for a specific term and shall hold office until the next general meeting of the Company and shall then be eligible for re-election at that meeting. Dr. Yan's appointment is subject to retirement by rotation at least once every three years and re- election at the annual general meeting of the Company in accordance with the articles of association of the Company. Dr. Yan will be entitled to receive a director's fee of HKD 120,000 per annum which was determined by the Board with reference to her duties and responsibilities within the Company as well as prevailing market rates. The Board announces that with effect from 11 July 2023, Mr. Chai Woon Chew ("Mr. Chai") resigned as an independent non-executive director, the chairman of remuneration committee and a member of audit committee and nomination committee due to his personal reasons. Mr. Chai and the Board have confirmed that Mr. Chai has no disagreement with the Board, and he is not aware of other matters in connection with his resignation that need to be brought to the attention of the shareholders of the Company and the Stock Exchange of Hong Kong Limited. The Board would like to express its sincere gratitude to Mr. Chai for his long and dedicated services for over 20 years to the Company, and in particular for his valuable contributions as an independent non-executive director. The Board wish him all the best in the future.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 SN3 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: SN3 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Elate Holdings 배당 수익률 vs 시장SN3의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (SN3)n/a시장 하위 25% (DE)1.5%시장 상위 25% (DE)4.5%업계 평균 (Electronic)0.9%분석가 예측 (SN3) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 SN3 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 SN3 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 SN3 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: SN3 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YDE 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/21 04:47종가2026/05/21 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Elate Holdings Limited는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Apr 27Elate Holdings Limited, Annual General Meeting, Jun 05, 2026Elate Holdings Limited, Annual General Meeting, Jun 05, 2026, at 11:00 China Standard Time.
공시 • Feb 06Elate Holdings Limited to Report Fiscal Year 2025 Results on Mar 30, 2026Elate Holdings Limited announced that they will report fiscal year 2025 results on Mar 30, 2026
공시 • Jul 02Elate Holdings Limited to Report First Half, 2025 Results on Aug 29, 2025Elate Holdings Limited announced that they will report first half, 2025 results on Aug 29, 2025
공시 • Apr 25Elate Holdings Limited, Annual General Meeting, Jun 06, 2025Elate Holdings Limited, Annual General Meeting, Jun 06, 2025, at 11:00 China Standard Time.
공시 • Feb 03Elate Holdings Limited to Report Fiscal Year 2024 Results on Mar 28, 2025Elate Holdings Limited announced that they will report fiscal year 2024 results on Mar 28, 2025
Reported Earnings • Sep 26First half 2024 earnings released: EPS: US$0.076 (vs US$0.001 in 1H 2023)First half 2024 results: EPS: US$0.076 (up from US$0.001 in 1H 2023). Revenue: US$65.8m (up 29% from 1H 2023). Net income: US$27.7m (up US$27.4m from 1H 2023). Profit margin: 42% (up from 0.6% in 1H 2023).
공시 • Jul 04Elate Holdings Limited to Report First Half, 2024 Results on Aug 30, 2024Elate Holdings Limited announced that they will report first half, 2024 results on Aug 30, 2024
공시 • Apr 28Elate Holdings Limited, Annual General Meeting, Jun 06, 2024Elate Holdings Limited, Annual General Meeting, Jun 06, 2024, at 11:00 China Standard Time. Agenda: To receive and adopt the Audited Financial Statements and the Reports of the Directors and Auditor for the year ended 31 December 2023; to re-elect the Ms. Zhang Xue as an executive director; to re-elect the Dr. Yan Shao Shi as an independent non-executive director; to authorize the board of directors to fix the remuneration of the aforesaid directors; to re-appoint BDO Limited as auditor and authorize the Board to fix their remuneration; and to consider other business matters.
Reported Earnings • Mar 30Full year 2023 earnings released: EPS: US$0.005 (vs US$0.002 in FY 2022)Full year 2023 results: EPS: US$0.005 (up from US$0.002 in FY 2022). Revenue: US$105.7m (up 5.5% from FY 2022). Net income: US$1.82m (up 217% from FY 2022). Profit margin: 1.7% (up from 0.6% in FY 2022).
공시 • Mar 01Elate Holdings Limited to Report Fiscal Year 2023 Results on Mar 28, 2024Elate Holdings Limited announced that they will report fiscal year 2023 results on Mar 28, 2024
Reported Earnings • Sep 03First half 2023 earnings released: EPS: US$0.001 (vs US$0.01 in 1H 2022)First half 2023 results: EPS: US$0.001 (down from US$0.01 in 1H 2022). Revenue: US$51.0m (down 3.6% from 1H 2022). Net income: US$300.0k (down 92% from 1H 2022). Profit margin: 0.6% (down from 6.7% in 1H 2022). The decrease in margin was primarily driven by lower revenue.
공시 • Aug 25Elate Holdings Limited Provides Group Earnings Guidance for the Six Months Ended 30 June 2023Elate Holdings Limited provided group earnings guidance for the six months ended 30 June 2023. For the period, the company is expected that the Group to record a net profit attributable to shareholders of approximately USD 0.3 million (corresponding period in 2022: net profit of approximately USD 3.5 million). The Board considers that the decrease in net profit for the six months ended 30 June 2023 was mainly attributable to the decrease in selling price of natural graphite products and increase in the cost of graphite production, which was mainly due to the over capacity of artificial graphite in China.
공시 • Jul 12Elate Holdings Limited Announces Executive ChangesThe board of directors (the "Board" or "Directors") of Elate Holdings Limited (the "Company") announce that with effect from 11 July 2023, Dr. Yan Shao Shi ("Dr. Yan") has been appointed as an independent non-executive director, the chairman of the Board's remuneration committee, a member of audit committee and nomination committee. Dr. Yan Shao Shi, aged 39, is currently an Assistant Professor and a Ph.D. Advisor in Macau University of Science and Technology. Dr. Yan obtained her doctoral degree from Macau University of Science and Technology, and her teaching and research areas include design, culture and communications. There is no service contract between the Company and Dr. Yan. She is not appointed for a specific term and shall hold office until the next general meeting of the Company and shall then be eligible for re-election at that meeting. Dr. Yan's appointment is subject to retirement by rotation at least once every three years and re- election at the annual general meeting of the Company in accordance with the articles of association of the Company. Dr. Yan will be entitled to receive a director's fee of HKD 120,000 per annum which was determined by the Board with reference to her duties and responsibilities within the Company as well as prevailing market rates. The Board announces that with effect from 11 July 2023, Mr. Chai Woon Chew ("Mr. Chai") resigned as an independent non-executive director, the chairman of remuneration committee and a member of audit committee and nomination committee due to his personal reasons. Mr. Chai and the Board have confirmed that Mr. Chai has no disagreement with the Board, and he is not aware of other matters in connection with his resignation that need to be brought to the attention of the shareholders of the Company and the Stock Exchange of Hong Kong Limited. The Board would like to express its sincere gratitude to Mr. Chai for his long and dedicated services for over 20 years to the Company, and in particular for his valuable contributions as an independent non-executive director. The Board wish him all the best in the future.